Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncological and functional results of robotic salvage radical prostatectomy after permanent brachytherapy implants.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2017
Same author

[Adjuvant radiotherapy for bladder cancer in patients with risk of locoregional recurrence: Who, what and how?]

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2017
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same author

[Treatments around surgery of prostate cancer and surgery of recurrence].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same author

Novel insights into nickel import in Staphylococcus aureus: the positive role of free histidine and structural characterization of a new thiazolidine-type nickel chelator.

Metallomics : integrated biometal science·2015
Same author

[Imagery of treated prostate cancer].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015

Related Experiment Video

Updated: Jul 7, 2026

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

[Adjuvant treatment after total prostatectomy].

P Richaud1

  • 1Institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux, France. Richaud@bergonie.org

Annales D'Urologie
|February 27, 2008
PubMed
Summary
This summary is machine-generated.

Adjuvant radiotherapy after prostatectomy reduces recurrence but not survival. Hormone therapy, LHRH agonists, and anti-androgens offer survival and disease-free benefits for specific patient groups, guiding treatment decisions.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Related Experiment Videos

Last Updated: Jul 7, 2026

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Area of Science:

  • Oncology
  • Urology
  • Medical Treatments

Context:

  • Radical prostatectomy is a primary treatment for prostate cancer.
  • Adjuvant therapies are employed to manage recurrence and metastasis risks post-surgery.
  • Treatment selection depends on pathological findings like lymph node status and surgical margins.

Purpose:

  • To review the efficacy of various adjuvant treatments following radical prostatectomy.
  • To delineate the benefits of radiotherapy, hormone therapy, and androgen deprivation in specific clinical scenarios.
  • To inform clinical decision-making for optimizing patient outcomes after prostate cancer surgery.

Summary:

  • Adjuvant radiotherapy after radical prostatectomy reduces biochemical recurrence risk but does not enhance overall survival.
  • For patients with metastasis risk, adjuvant hormone therapy warrants discussion.
  • Luteinizing hormone-releasing hormone (LHRH) agonists improve overall survival in positive lymph node cases.
  • Non-steroidal anti-androgens improve disease-free survival in pT3 patients with positive surgical margins.

Impact:

  • Provides evidence-based guidance for selecting adjuvant treatments post-prostatectomy.
  • Aims to improve patient survival and reduce recurrence rates through tailored therapeutic strategies.
  • Highlights the differential benefits of various adjuvant therapies based on patient-specific risk factors.